Chondroitinase ABC promotes functional recovery after spinal cord injury
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervous system (CNS) can lead to permanent paralysis. At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs). CSPGs are inhibitory to axon growth in vitro, and regenerating axons stop at CSPG-rich regions in vivo. Removing CSPG glycosaminoglycan (GAG) chains attenuates CSPG inhibitory activity. To test the functional effects of degrading chondroitin sulphate (CS)-GAG after spinal cord injury, we delivered chondroitinase ABC (ChABC) to the lesioned dorsal columns of adult rats. We show that intrathecal treatment with ChABC degraded CS-GAG at the injury site, upregulated a regeneration-associated protein in injured neurons, and promoted regeneration of both ascending sensory projections and descending corticospinal tract axons. ChABC treatment also restored post-synaptic activity below the lesion after electrical stimulation of corticospinal neurons, and promoted functional recovery of locomotor and proprioceptive behaviours. Our results demonstrate that CSPGs are important inhibitory molecules in vivo and suggest that their manipulation will be useful for treatment of human spinal injuries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Degradation of PNNs has been shown to reactivate early life-like plasticity also in the spinal cord and fear circuitry189,190.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“In rats, iPlasticity induced either by ChABC or fluoxetine improves recovery from spinal cord lesion189,201.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“As chABC removes GAG side chains from CSPGs (Bradbury et al., 2002), these results suggest that the neuroprotective effects of PNNs may be attributed to the CS-side chains of CSPGs.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“CSPG degradation via application of chABC promoted regeneration of dorsal column axons after injury.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“but also contributed to expanded receptive fields of uninjured primary afferents (Bradbury et al., 2002; Massey et al., 2006).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 1×
“At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs)”
BackgroundSelf-citationMcKeon, R., Schreiber, R., Rudge, J., & Silver, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03398.1991 · Cited by 1,188
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors
Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D., & Schwab, M. E. (1995) · Nature · doi:10.1038/378498a0 · Cited by 716
Davies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 1×
“, and regenerating axons stop at CSPG-rich regions in vivo”
BackgroundMoon, L. D. F., Asher, R. A., Rhodes, K. E., & Fawcett, J. W. (2001) · Nature Neuroscience · doi:10.1038/87415 · Cited by 562
Self-citationFunctional regeneration of sensory axons into the adult spinal cord
Ramer, M. S., Priestley, J. V., & McMahon, S. B. (2000) · Nature · doi:10.1038/35002084 · Cited by 517
Self-citationMckeon, R. J., Höke, A., & Silver, J. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1081 · Cited by 486
Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes
Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H., & Fawcett, J. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02427.2000 · Cited by 482
Self-citationMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury
Levine, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04716.1994 · Cited by 393
Cited by
Items 101–200 of 1,014
Ertürk, A., Mauch, C. P., Hellal, F., Förstner, F., Keck, T., Becker, K., Jährling, N., Steffens, H., Richter, M., Hübener, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2600 · Cited by 321
Zhong, Y., & Bellamkonda, R. V. (2007) · Brain Research · doi:10.1016/j.brainres.2007.02.024 · Cited by 321
“Following chondroitinase treatment, glycosaminoglycan removal enhances neurite outgrowth, suggesting an inhibitory role for CSPGs (Bradbury et al., 2002).”
BackgroundMenet, V., Prieto, M., Privat, A., & Ribotta, M. G. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533187100 · Cited by 317
Lee, H., McKeon, R. J., & Bellamkonda, R. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905437106 · Cited by 313
“chABC, a bacterial enzyme that digests the chondroitin sulfate glycosaminoglycans (CS-GAGs) of CSPGs, promotes axonal sprouting and functional recovery in various animal models (4).”
BackgroundMassey, J. M., Hubscher, C. H., Wagoner, M. R., Decker, J. A., Amps, J., Silver, J., & Onifer, S. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5467-05.2006 · Cited by 320
“…with other treatments, chABC application has led to several reports of axon regeneration and functional recovery (McKeon et al., 1991, 1999; Yick et al., 2000, 2003; Moon et al., 2001; Bradbury et al., 2002; Chau et al., 2004; Caggiano et al., 2005; Fouad et al., 2005; Steinmetz et al., 2005).”
BackgroundResultInfluentialMechanics in Neuronal Development and Repair
Franze, K., Janmey, P. A., & Guck, J. (2013) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150045 · Cited by 314
Manipulating the glial scar: Chondroitinase ABC as a therapy for spinal cord injury
Bradbury, E. J., & Carter, L. M. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.06.015 · Cited by 314
Self-citationHoule, J. D., Tom, V. J., Mayes, D., Wagoner, G., Phillips, N., & Silver, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1166-06.2006 · Cited by 311
“…of highly invasive bacteria to cleave the inhibitory side chains, has been used in mammals to degrade GAGs at spinal cord lesion sites, resulting in enhanced axonal regrowth and restoration of some downstream postsynaptic activity (Bradbury et al., 2002; Chau et al., 2004; Caggiano et al., 2005).”
BackgroundSun, G., Li, G., Li, D., Huang, W., Zhang, R., Zhang, H., Duan, Y., & Wang, B. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.04.006 · Cited by 314
Stokols, S., & Tuszynski, M. H. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.06.039 · Cited by 309
Sivasankaran, R., Pei, J., Wang, K. C., Zhang, Y. P., Shields, C. B., Xu, X.-M., & He, Z. (2004) · Nature Neuroscience · doi:10.1038/nn1193 · Cited by 315
“Similarly, the CSPG components of the glial scar seem to have a key role in restricting axon regeneration in the adult CNS, as enzymatic removal of these molecules from the lesion sites improves axon regeneration and functional recover”
BackgroundAstrocyte reactivity and astrogliosis after spinal cord injury
Okada, S., Hara, M., Kobayakawa, K., Matsumoto, Y., & Nakashima, Y. (2018) · Neuroscience Research · doi:10.1016/j.neures.2017.10.004 · Cited by 313
Sasaki, M., Radtke, C., Tan, A. M., Zhao, P., Hamada, H., Houkin, K., Honmou, O., & Kocsis, J. D. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2769-09.2009 · Cited by 309
“Because of its expression pattern in the spinal cord motor system, specifically in rodent species, PKC-γ has been shown to be useful for investigating CST sprouting and plasticity in SCI models (Bradbury et al., 2002; Barritt et al., 2006; Cafferty and Strittmatter, 2006).”
BackgroundFisher, D., Xing, B., Dill, J., Li, H., Hoang, H. H., Zhao, Z., Yang, X.-L., Bachoo, R., Cannon, S., Longo, F. M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1737-11.2011 · Cited by 312
“…suppression and enhances axonal regeneration of nigrostriatal, corticospinal, and ascending fibers, and improving functional recovery after CNS injuries (Moon et al., 2001; Bradbury et al., 2002; Cafferty et al., 2007; García-Alías et al., 2008; Tester and Howland, 2008; Jefferson et al., 2011).”
BackgroundInfluentialThe translational landscape in spinal cord injury: focus on neuroplasticity and regeneration
Hutson, T. H., & Di Giovanni, S. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0280-3 · Cited by 302
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
Rhodes, K. E., & Fawcett, J. W. (2004) · Journal of Anatomy · doi:10.1111/j.1469-7580.2004.00261.x · Cited by 296
“2001) or dorsal column (Bradbury et al. 2002) with chondroitinase degraded CS-GAG around the lesion site and promoted axonal regeneration.”
BackgroundSelf-citationLi, S., Liu, B. P., Budel, S., Li, M., Ji, B., Walus, L., Li, W., Jirik, A., Rabacchi, S., Choi, E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2828-04.2004 · Cited by 306
“Axon growth in the adult mammalian CNS is inhibited in part by myelinderived inhibitors (Schwab and Caroni, 1988; Savio and Schwab, 1989; McGee and Strittmatter, 2003) and in part by glial scarderived chondroitin sulfate proteoglycans (Snow et al., 1990; Davies et al., 1999; Bradbury et al., 2002).”
BackgroundDelayed Systemic Nogo-66 Receptor Antagonist Promotes Recovery from Spinal Cord Injury
Li, S., & Strittmatter, S. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04219.2003 · Cited by 305
“…of myelin-derived growth inhibitors (Bregman et al., 1995; Thallmair et al., 1998; GrandPre et al., 2002), reduction of the scar-issue barrier (Bradbury et al., 2002), enhancement of the growth potential of neurons (Bomze et al., 2001; Dergham et al., 2002; Neumann et al., 2002; Qiu et al.,…”
BackgroundMethodInfluentialCan regenerating axons recapitulate developmental guidance during recovery from spinal cord injury?
Harel, N. Y., & Strittmatter, S. M. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1957 · Cited by 300
Biernaskie, J., Sparling, J. S., Liu, J., Shannon, C. P., Plemel, J. R., Xie, Y., Miller, F. D., & Tetzlaff, W. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1930-07.2007 · Cited by 302
“…considered to be one of the negative sequelae of spinal cord injury, because they inhibit axonal growth and contribute to the barrier imposed by the astrocytic scar (Fitch and Silver, 1997; Bradbury et al., 2002; Borisoff et al., 2003; Jones et al., 2003; Monnier et al., 2003; Tang et al., 2003).”
BackgroundBareyre, F. M., & Schwab, M. E. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.004 · Cited by 302
REVIEW OF TREATMENT TRIALS IN HUMANSPINAL CORD INJURY: ISSUES, DIFFICULTIES, AND RECOMMENDATIONS
Tator, C. H. (2006) · Neurosurgery · doi:10.1227/01.neu.0000245591.16087.89 · Cited by 303
“Some very promising strategies in animal studies, including chondroitinase abc (23), genetic engineering, and implanted guidance channels (166), have not yet been reported in human SCI trials.”
BackgroundAbematsu, M., Tsujimura, K., Yamano, M., Saito, M., Kohno, K., Kohyama, J., Namihira, M., Komiya, S., & Nakashima, K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42957 · Cited by 302
The Nogo-66 receptor: focusing myelin inhibition of axon regeneration
McGee, A. W., & Strittmatter, S. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00062-6 · Cited by 298
Moreau-Fauvarque, C., Kumanogoh, A., Camand, E., Jaillard, C., Barbin, G., Boquet, I., Love, C., Jones, E. Y., Kikutani, H., Lubetzki, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09229.2003 · Cited by 293
“Infusion of the enzyme chondroitinase ABC, which denudes the core proteins of the CS-PG of their GAG chains, promotes regeneration of nigrostriatal axons (Moon et al., 2001) and spinal cord axons ( Bradbury et al., 2002 ).”
BackgroundGLYCOMICS APPROACH TO STRUCTURE-FUNCTION RELATIONSHIPS OF GLYCOSAMINOGLYCANS
Sasisekharan, R., Raman, R., & Prabhakar, V. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095745 · Cited by 278
Molecular basis of plasticity in the visual cortex
Berardi, N., Pizzorusso, T., Ratto, G. M., & Maffei, L. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00168-1 · Cited by 288
Reactive gliosis in the pathogenesis of CNS diseases
Pekny, M., & Pekna, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.014 · Cited by 275
The enzyme as drug: application of enzymes as pharmaceuticals
Vellard, M. (2003) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(03)00092-2 · Cited by 283
Li, Y., Decherchi, P., & Raisman, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00727.2003 · Cited by 286
“This provides a simpler experimental model for studying the effects of different candidate reparative cell types and molecular interventions (Thallmair et al., 1998; Tang et al., 2001; Bradbury et al., 2002).”
MethodNeuronal plasticity and neurotrophic factors in drug responses
Castrén, E., & Antila, H. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.61 · Cited by 284
Jones, L. L., Sajed, D., & Tuszynski, M. H. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09276.2003 · Cited by 283
“In addition, upregulation of a general CSPG marker correlates with aborted axon growth (Davies et al., 1997), and degradation of associated chondroitins after brain injury (Moon et al., 2001) and spinal cord injury (SCI) (Bradbury et al., 2002) partially enhances axon growth and functional recovery.”
BackgroundRole of the lesion scar in the response to damage and repair of the central nervous system
Kawano, H., Kimura-Kuroda, J., Komuta, Y., Yoshioka, N., Li, H. P., Kawamura, K., Li, Y., & Raisman, G. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1336-5 · Cited by 273
“It has been reported that degradation of CSPG by injection of ChABC into the lesion site enhances regeneration of nigrostriatal ascending (Moon et al. 2001) and spinal descending (Bradbury et al. 2002) systems.”
BackgroundInfluentialRamer, L. M., Au, E., Richter, M. W., Liu, J., Tetzlaff, W., & Roskams, A. J. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20049 · Cited by 277
“Glial scar permeability was evident despite the expression of CSPGs, which are generally considered inhibitory to neurite outgrowth, around OECtreated lesions (McKeon et al., 1995; Anderson et al., 1998; Bradbury et al., 2002).”
BackgroundOvercoming Inhibition in the Damaged Spinal Cord
Fawcett, J. W. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.371 · Cited by 279
“This treatment has been applied to injuries in the brain and spinal cord, producing both axon regeneration and recovery of function (Yick et al., 2000; Moon et al., 2001; Bradbury et al., 2002; Fouad et al., 2005; Caggiano et al., 2005).”
Self-citationChondroitin/dermatan sulfate in the central nervous system
Sugahara, K., & Mikami, T. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.08.015 · Cited by 273
Rolls, A., Shechter, R., London, A., Segev, Y., Jacob-Hirsch, J., Amariglio, N., Rechavi, G., & Schwartz, M. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050171 · Cited by 271
“Some of the most important lines of evidence supporting a negative effect of CSPG on CNS repair come from studies in which degradation of CSPG by ChABC, even if it is administered immediately after an insult [1,12], results in improved recovery.”
BackgroundMethodInfluentialZhou, X., Wahane, S., Friedl, M.-S., Kluge, M., Friedel, C. C., Avrampou, K., Zachariou, V., Guo, L., Zhang, B., He, X., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0597-7 · Cited by 275
Blackmore, M. G., Wang, Z., Lerch, J. K., Motti, D., Zhang, Y. P., Shields, C. B., Lee, J. K., Goldberg, J. L., Lemmon, V. P., & Bixby, J. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120684109 · Cited by 272
“Therapeutic combination targets could include extracellular inhibitory molecules (5, 46), stimulation by neurotrophins or cytokines (47, 48), and a wide range of regeneration-associated transcription factors (e.”
BackgroundAlia, C., Spalletti, C., Lai, S., Panarese, A., Lamola, G., Bertolucci, F., Vallone, F., Di Garbo, A., Chisari, C., Micera, S., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00076 · Cited by 250
The astrocyte in multiple sclerosis revisited
Brosnan, C. F., & Raine, C. S. (2013) · Glia · doi:10.1002/glia.22443 · Cited by 259
“…such as chondroitin sulfate proteoglycans (CSPGs), that inhibit neurite outgrowth and axonal regeneration (reviewed in Fawcett, 2006; Rolls et al., 2009; Silver and Miller, 2004), and enzymes that degrade CSPGs have shown promise in animal models of spinal cord injury (Bradbury et al., 2002).”
BackgroundThe Role of Astrocytes in Multiple Sclerosis Progression
Correale, J., & Farez, M. F. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00180 · Cited by 261
“There is clear evidence that CSPGs are produced in excess by astrocytes when they become reactive and that inhibitory activity of CSPGs depends on the GAG component, as removal of GAG chains from the protein core eliminates inhibition (104, 111).”
BackgroundCrosstalk between glia, extracellular matrix and neurons
Song, I., & Dityatev, A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.03.003 · Cited by 262
“Intrathecal injection of ChABC after spinal cord injury upregulates regeneration-associated proteins, promote regeneration of sensory projections and corticospinal tract axons and behavior recovery (Bradbury et al., 2002; Huang et al., 2006).”
BackgroundDissecting the Dual Role of the Glial Scar and Scar-Forming Astrocytes in Spinal Cord Injury
Yang, T., Dai, Y., Chen, G., & Cui, S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00078 · Cited by 252
“Chondroitinase ABC, an enzyme that degrades the CSPG glycosaminoglycan chains, is a representative intervention targeting CSPGs. Chondroitinase ABC can attenuate the inhibitory activity of CSPGs and promote axonal regeneration (Bradbury et al., 2002; Pakulska et al., 2017).”
BackgroundMultiple-channel scaffolds to promote spinal cord axon regeneration
Moore, M. J., Friedman, J. A., Lewellyn, E. B., Mantila, S. M., Krych, A. J., Ameenuddin, S., Knight, A. M., Lu, L., Currier, B. L., Spinner, R. J., et al. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.07.045 · Cited by 266
Okada, S., Nakamura, M., Mikami, Y., Shimazaki, T., Mihara, M., Ohsugi, Y., Iwamoto, Y., Yoshizaki, K., Kishimoto, T., Toyama, Y., et al. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20044 · Cited by 264
“Bradbury et al. (2002) also demonstrated that degradation of chondroitin sulfate proteoglycans that are contained in glial scars at injury site with chondroitinase ABC improved functional recovery and promoted regeneration of both ascending sensory projections and descending long tract axons.”
BackgroundPolymeric Systems for Bioprinting
Bedell, M. L., Navara, A. M., Du, Y., Zhang, S., & Mikos, A. G. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00834 · Cited by 258
Tom, V. J., Steinmetz, M. P., Miller, J. H., Doller, C. M., & Silver, J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0994-04.2004 · Cited by 259
“…sugar chains of PGs have recently been shown to enhance regeneration and provide some functional recovery after injury (Moon et al., 2001; Bradbury et al., 2002; Mayes and Houle, 2003; Tester et al., 2003; Grimpe and Silver, 2004), illustrating their importance in regeneration failure;…”
BackgroundVenkatesh, K., Ghosh, S. K., Mullick, M., Manivasagam, G., & Sen, D. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03039-1 · Cited by 251
Astrocytes as a Source for Extracellular Matrix Molecules and Cytokines
Wiese, S., Karus, M., & Faissner, A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00120 · Cited by 262
“Beyond a role as obstacles to regeneration, CSPGs have also been implicated in the regulation of synaptic plasticity (Bradbury et al., 2002; Pizzorusso et al., 2002; Faissner et al., 2010).”
BackgroundChondroitin proteoglycans are involved in cell division of Caenorhabditis elegans
Mizuguchi, S., Uyama, T., Kitagawa, H., Nomura, K. H., Dejima, K., Gengyo-Ando, K., Mitani, S., Sugahara, K., & Nomura, K. (2003) · Nature · doi:10.1038/nature01635 · Cited by 260
“Undersulphated and oversulphated chondroitin sulphate chains have been implicated in other biological processes, however, including adhesion of erythrocytes infected with malaria parasite to human placenta and regulation of neural developmen”
BackgroundConditioning Injury-Induced Spinal Axon Regeneration Fails in Interleukin-6 Knock-Out Mice
Cafferty, W. B. J., Gardiner, N. J., Das, P., Qiu, J., McMahon, S. B., & Thompson, S. W. N. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2245-02.2004 · Cited by 261
Self-citationChondroitin sulfate proteoglycans in demyelinated lesions impair remyelination
Lau, L. W., Keough, M. B., Haylock‐Jacobs, S., Cua, R., Döring, A., Sloka, S., Stirling, D. P., Rivest, S., & Yong, V. W. (2012) · Annals of Neurology · doi:10.1002/ana.23599 · Cited by 245
“Chondroitinase ABC (ChABC) is a bacterial enzyme that degrades the glycosaminoglycan (GAG) chains of CSPGs while leaving the core protein relatively intact.(21) We incubated CSPGs with ChABC (0.”
MethodTaxol Facilitates Axon Regeneration in the Mature CNS
Sengottuvel, V., Leibinger, M., Pfreimer, M., Andreadaki, A., & Fischer, D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4885-10.2011 · Cited by 254
“Given that the inactivation of inhibitory CSPGs by chondroitinase ABC improves axon regeneration in the CNS, in particular when combined with an enhancement of the intrinsic growth capacity of neurons (Moon et al., 2001; Bradbury et al., 2002; Steinmetz et al., 2005), it is possible that the reduction in CSPG expressi…”
BackgroundProgression in translational research on spinal cord injury based on microenvironment imbalance
Fan, B., Wei, Z., & Feng, S. (2022) · Bone Research · doi:10.1038/s41413-022-00199-9 · Cited by 240
“Therefore, it is unclear whether CSPGs produced by the astrocytic scar are the main factors underlying the inability of axons to regenerate across the SCI lesion.(95,96) Astrogliosis might exacerbate the inflammatory response after trauma or autoimmune attack.”
BackgroundImmune response following traumatic spinal cord injury: Pathophysiology and therapies
Sterner, R. C., & Sterner, R. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1084101 · Cited by 234
Stem cell therapies for spinal cord injury
Sahni, V., & Kessler, J. A. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.73 · Cited by 243
Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
Yamada, S., & Sugahara, K. (2008) · Current Drug Discovery Technologies · doi:10.2174/157016308786733564 · Cited by 241
“Since removal or reduction of the CS/DS chains in the lesion zone by enzymatic digestion promotes the regeneration of neurites in the spinal cord [110], CS/DS moieties of CS/DS-PGs are considered to be necessary parts of the inhibitory structures.”
BackgroundSchwann Cell Transplantation for Repair of the Adult Spinal Cord
Oudega, M., & Xu, X.-M. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.453 · Cited by 243
“Bradbury et al. (2002) used a dorsal column lesion model to demonstrate that intrathecal treatment with chondroitinase ABC (Ch ase ABC), a bacterial enzyme that cleaves off the biological active side chains of the core proteoglycan molecule of CSPGs, promotes regeneration of both ascending sensory…”
Promoting axonal rewiring to improve outcome after stroke
Benowitz, L. I., & Carmichael, S. T. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.009 · Cited by 246
Targeting the neural extracellular matrix in neurological disorders
Soleman, S., Filippov, M. A., Dityatev, A., & Fawcett, J. W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.050 · Cited by 244
“10 S. Soleman et al. / Neuroscience xxx (2013) xxx–xxx regeneration after administration of chABC (Bradbury et al., 2002a).”
BackgroundResultSelf-citationHurtado, A., Cregg, J. M., Wang, H. B., Wendell, D. F., Oudega, M., Gilbert, R. J., & McDonald, J. W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.006 · Cited by 240
Chondroitin-4-sulfation negatively regulates axonal guidance and growth
Wang, H., Katagiri, Y., McCann, T. E., Unsworth, E., Goldsmith, P., Yu, Z.-X., Tan, F., Santiago, L., Mills, E. M., Wang, Y., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.032649 · Cited by 243
“cABC treatment enhances axonal growth and functional recovery after spinal cord injury (Bradbury et al., 2002).”
BackgroundAstrocyte activation and reactive gliosis—A new target in stroke?
Pekny, M., Wilhelmsson, U., Tatlisumak, T., & Pekna, M. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.07.021 · Cited by 233
Glial Cells Shape Pathology and Repair After Spinal Cord Injury
Gaudet, A. D., & Fonken, L. K. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0630-7 · Cited by 228
“[119] found that ChABC treatment after C4 dorsal column crush lesion improved corticospinal axon regeneration, functional axon reconnection (using electrophysiology), and recovery of sensorimotor function (tape removal and walking tests).”
BackgroundBareyre, F. M., Garzorz, N., Lang, C., Misgeld, T., Büning, H., & Kerschensteiner, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015239108 · Cited by 234
“Bradbury EJ, et al. (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury.”
MethodInfluentialHsu, J.-Y. C., McKeon, R., Goussev, S., Werb, Z., Lee, J.-U., Trivedi, A., & Noble-Haeusslein, L. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1993-06.2006 · Cited by 233
“Enzymatic treatment of the injured spinal cord with chondroitinase ABC, which attenuates CSPG activity, markedly improves axonal regeneration and functional recovery (Bradbury et al., 2002; Chau et al., 2004).”
BackgroundBiomaterials for cell transplantation
Mitrousis, N., Fokina, A., & Shoichet, M. S. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0057-0 · Cited by 233
Neuronal Plasticity: Beyond the Critical Period
Hübener, M., & Bonhoeffer, T. (2014) · Cell · doi:10.1016/j.cell.2014.10.035 · Cited by 237
Dityatev, A., Seidenbecher, C. I., & Schachner, M. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.08.003 · Cited by 236
Contrasting the Glial Response to Axon Injury in the Central and Peripheral Nervous Systems
Brosius Lutz, A., & Barres, B. A. (2014) · Developmental Cell · doi:10.1016/j.devcel.2013.12.002 · Cited by 234
Inactivation of Glycogen Synthase Kinase 3 Promotes Axonal Growth and Recovery in the CNS
Dill, J., Wang, H., Zhou, F., & Li, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1178-08.2008 · Cited by 229
“Chondroitin sulfate proteoglycans generated by astroglial scar around lesions strongly suppress axonal extension via unknown receptor(s) (Bradbury et al., 2002; Silver and Miller, 2004).”
BackgroundRomberg, C., Yang, S., Melani, R., Andrews, M. R., Horner, A. E., Spillantini, M. G., Bussey, T. J., Fawcett, J. W., Pizzorusso, T., & Saksida, L. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.6267-11.2013 · Cited by 231
“Overall, our data suggest that the removal of PNNs not only promotes plasticity and regeneration of sensory/motor systems (Bradbury et al., 2002; Carulli et al., 2010), but also facilitates cognitive abilities in adults by altering the rules of underlying, experience-driven synaptic plasticity.”
BackgroundSelf-citationYang, C.-C., Shih, Y.-H., Ko, M.-H., Hsu, S.-Y., Cheng, H., & Fu, Y.-S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003336 · Cited by 228
“Degradation of chondroitin sulphate proteoglycans by chondroitinases has been demonstrated to improve functional recovery after brain and spinal cord injuries [58–61].”
BackgroundAhuja, C. S., & Fehlings, M. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0381 · Cited by 220
Extracellular matrix regulation of inflammation in the healthy and injured spinal cord
Gaudet, A. D., & Popovich, P. G. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.020 · Cited by 215
“In addition, astrocytes adjacent to the lesion form a matrix-rich glial scar, which limits the extent of hemorrhagic damage and leukocyte migration but also restricts axon plasticity (Alilain et al., 2011; Bradbury et al., 2002; Faulkner et al., 2004; McKeon et al., 1991; Wanner et al., 2013).”
BackgroundKhaing, Z. Z., Milman, B. D., Vanscoy, J. E., Seidlits, S. K., Grill, R. J., & Schmidt, C. E. (2011) · Journal of Neural Engineering · doi:10.1088/1741-2560/8/4/046033 · Cited by 216
Bartus, K., James, N. D., Didangelos, A., Bosch, K. D., Verhaagen, J., Yáñez-Muñoz, R. J., Rogers, J. H., Schneider, B. L., Muir, E. M., & Bradbury, E. J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4369-13.2014 · Cited by 219
“In vivo delivery of this enzyme has led to beneficial effects on repair following experimental spinal cord injury in models involving partial (Bradbury et al., 2002; Houle et al., 2006; Massey et al., 2006; Cafferty et al., 2008; García-Alías et al., 2009; Alilain et al., 2011; Jefferson et al.,…”
BackgroundMethodSelf-citationCafferty, W. B. J., Yang, S.-H., Duffy, P. J., Li, S., & Strittmatter, S. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5176-06.2007 · Cited by 223
“Both axonal growth and functional regeneration have been observed after infusion of ChABC via a CNS catheter into rodents with spinal cord or brain injury (Yick et al., 2000; Bradbury et al., 2002; Caggiano et al., 2005; Barritt et al., 2006).”
InfluentialInjectable hydrogels for central nervous system therapy
Pakulska, M. M., Ballios, B. G., & Shoichet, M. S. (2012) · Biomedical Materials · doi:10.1088/1748-6041/7/2/024101 · Cited by 216
“BDNF delivered in this way was found to reduce the reactivity of the astrocytes and the production of chondroitin sulfate proteoglycans (CSPGs) and enhanced the number of regenerating fibres that entered the hydrogel chondroitinase ABC-loaded lipid microtubules to the injured spinal cord in rats [36, 48].”
InfluentialTherapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem
Griffin, J. M., & Bradke, F. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911505 · Cited by 224
“Intrathecal infusion of ChABC for 10 days into rats following C4 dorsal column crush lesion degraded CSPGs, increased CST-axonal regeneration and improved functional scores on several behavioural tests (Bradbury et al, 2002).”
Wright, K. T., Masri, W. E., Osman, A., Chowdhury, J., & Johnson, W. E. B. (2011) · Stem Cells · doi:10.1002/stem.570 · Cited by 216
Reinhard, S. M., Razak, K., & Ethell, I. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00280 · Cited by 219
“Conversely in the mossy fiber-CA3 pathway, where LTP is also MMP-9 dependent, LTP occurs at presynaptic sites and is independent of NMDA receptors (Harris and Cotman, 1986; Castillo et al., 1997; Wiera et al., 2013).”
BackgroundChondroitin sulfate proteoglycans in neural development and regeneration
Laabs, T., Carulli, D., Geller, H. M., & Fawcett, J. W. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.01.014 · Cited by 205
Self-citationOvercoming Macrophage-Mediated Axonal Dieback Following CNS Injury
Busch, S. A., Horn, K. P., Silver, D. J., & Silver, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1151-09.2009 · Cited by 213
“Numerous studies have shown that digestion of inhibitory CSPGs with the bacterial enzyme ChABC increases axonal growth both in vitro and in vivo (Bradbury et al., 2002; Steinmetz et al., 2005).”
BackgroundKeough, M. B., Rogers, J. A., Zhang, P., Jensen, S. K., Stephenson, E. L., Chen, T., Hurlbert, M. G., Lau, L. W., Rawji, K. S., Plemel, J. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11312 · Cited by 210
“Given that chondroitinase ABC must be administered via local injection into injury sites, we deemed it impractical for demyelinating diseases such as MS where lesions arise all throughout the brain and spinal cord.”
InfluentialKochlamazashvili, G., Henneberger, C., Bukalo, O., Dvoretskova, E., Senkov, O., Lievens, P. M.-J., Westenbroek, R., Engel, A. K., Catterall, W. A., Rusakov, D. A., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.030 · Cited by 215
“This observation highlights the importance of the ECM in memory formation and/or maintenance, in agreement with recent studies showing that removal of chondroitin sulfates or deficiency in tenascin-R, both of which are known to improve regeneration (Bradbury et al., 2002; Apostolova et al., 2006), also promotes format…”
BackgroundResultInfluentialIdentification of a Spinal Circuit for Light Touch and Fine Motor Control
Bourane, S., Grossmann, K. S., Britz, O., Dalet, A., Del Barrio, M. G., Stam, F. J., Garcia-Campmany, L., Koch, S., & Goulding, M. (2015) · Cell · doi:10.1016/j.cell.2015.01.011 · Cited by 215
THE NOGO SIGNALING PATHWAY FOR REGENERATION BLOCK
He, Z., & Koprivica, V. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144340 · Cited by 215
New approaches for brain repair-from rescue to reprogramming
Barker, R. A., Götz, M., & Parmar, M. (2018) · Nature · doi:10.1038/s41586-018-0087-1 · Cited by 214
Wang, D., Ichiyama, R. M., Zhao, R., Andrews, M. R., & Fawcett, J. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0983-11.2011 · Cited by 205
“…enzyme chondroitinase ABC (ChABC), which digests extracellular chondroitin sulfate proteoglycans (CSPGs), has been shown to enhance axonal regeneration both in vitro and in vivo (Zuo et al., 1998; Yick et al., 2000, 2003; Bradbury et al., 2002; Moon et al., 2002; Tester and Howland, 2008).”
BackgroundMethodInfluentialSelf-citationChemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury
Alto, L. T., Havton, L. A., Conner, J. M., Hollis II, E. R., Blesch, A., & Tuszynski, M. H. (2009) · Nature Neuroscience · doi:10.1038/nn.2365 · Cited by 212
Experimental strategies to promote spinal cord regeneration—an integrative perspective
Schwab, J. M., Brechtel, K., Mueller, C.-A., Failli, V., Kaps, H.-P., Tuli, S. K., & Schluesener, H. J. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.12.004 · Cited by 208
The glial scar in spinal cord injury and repair
Yuan, Y.-M., & He, C. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1358-3 · Cited by 212
“ChABC Moderate Intracellular energy ↓Scar tissue Better BBB open [4]”
BackgroundSuppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates
Borisoff, J. F., Chan, C. C. M., Hiebert, G. W., Oschipok, L., Robertson, G. S., Zamboni, R., Steeves, J. D., & Tetzlaff, W. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(02)00032-5 · Cited by 210
Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury
Zhou, Y., Shao, A., Yao, Y., Tu, S., Deng, Y., & Zhang, J. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00549-2 · Cited by 204
Steward, O., Zheng, B., & Tessier‐Lavigne, M. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10593 · Cited by 214
Steinmetz, M. P., Horn, K. P., Tom, V. J., Miller, J. H., Busch, S. A., Nair, D., Silver, D. J., & Silver, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2111-05.2005 · Cited by 205
“Thus, ChABC may improve function after CNS injury via its effects on plasticity, in addition to the promotion of frank regeneration (Bradbury et al., 2002).”
BackgroundInfluentialAligned neurite outgrowth and directed cell migration in self-assembled monodomain gels
Berns, E. J., Sur, S., Pan, L., Goldberger, J. E., Suresh, S., Zhang, S., Kessler, J. A., & Stupp, S. I. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.077 · Cited by 208
Macrophages and microglia in central nervous system injury: are they helpful or harmful?
Schwartz, M. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200304000-00001 · Cited by 207
“Similarly, regrowth was promoted by treatment with proteases that degrade chondroitin sulfate proteoglycans (Bradbury et al., 2002; Rudge and Silver, 1990).”
Background
Metadata
- Authors
- Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B.
- Affiliations
- King's College London (GB)
- University of Cambridge (GB)
- University of London (GB)
- Corresponding author
- Bradbury, Elizabeth J.
- ORCID
- Venue
- Nature
- Published
- 2002-04
- Volume
- 416
- Issue
- 6881
- Pages
- 636-640
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2012928251
- Cited by
- 2,357
- References
- 31
- Citations by year
- 2026: 63 · 2025: 75 · 2024: 54 · 2023: 73 · 2022: 98 · 2021: 95 · 2020: 116 · 2019: 91 · 2018: 109 · 2017: 96 · 2016: 104 · 2015: 111 · 2014: 131 · 2013: 108 · 2012: 137
- FWCI
- 63.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- chondroitinase ABC, spinal cord injury, chondroitin sulfate proteoglycans, glycosaminoglycan degradation, axon regeneration, glial scar, corticospinal tract, sensory axon regeneration, locomotor recovery, proprioception, central nervous system injury
- MeSH terms
- Animals, Axons, Electrophysiology, Ganglia, Spinal, Humans, Isoenzymes, Male, Motor Activity, Nerve Crush, Nerve Regeneration, Neurons, Protein Kinase C, Psychomotor Performance, Spinal Cord Injuries, Up-Regulation, Rats, Wistar, Chondroitin ABC Lyase, GAP-43 Protein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.